Cytomegalovirus anterior uveitis and occlusive retinal vasculitis without retinitis in a patient on immunomodulatory therapy
Purpose To describe unusual clinical features and therapeutic management of a case of cytomegalovirus (CMV) ocular disease in a patient on immunomodulatory therapy. Setting/venue Moorfields Eye Hospital NHS Foundation Trust, London, UK. Methods Medical history, clinical findings, investigation results, and multimodal imaging were retrospectively collected. Results A 61-year-old, South-East Asian man, developed CMV-related endotheliitis and occlusive retinal vasculitis, diagnosed by wide-angle fluorescein angiography. No retinitis was present on the fundus examination. Suspicion of CMV etiology was based on anterior segment findings, especially the presence of coin-shaped endothelial lesions. The diagnosis was confirmed by aqueous polymerase chain reaction (PCR) analysis which was positive for CMV DNA. The combined use of topical and systemic valganciclovir resulted in significant improvement of the picture. Conclusions CMV can manifest in the eye as occlusive retinal vasculitis without the presence of typical retinitis..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
Journal of ophthalmic inflammation and infection - 13(2023), 1 vom: 04. Aug. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Fabozzi, Lorenzo [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Cytomegalovirus virus |
|---|
| Anmerkungen: |
© The Author(s) 2023 |
|---|
| doi: |
10.1186/s12348-023-00356-z |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR052642690 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR052642690 | ||
| 003 | DE-627 | ||
| 005 | 20231119064751.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230805s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12348-023-00356-z |2 doi | |
| 035 | |a (DE-627)SPR052642690 | ||
| 035 | |a (SPR)s12348-023-00356-z-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Fabozzi, Lorenzo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cytomegalovirus anterior uveitis and occlusive retinal vasculitis without retinitis in a patient on immunomodulatory therapy |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s) 2023 | ||
| 520 | |a Purpose To describe unusual clinical features and therapeutic management of a case of cytomegalovirus (CMV) ocular disease in a patient on immunomodulatory therapy. Setting/venue Moorfields Eye Hospital NHS Foundation Trust, London, UK. Methods Medical history, clinical findings, investigation results, and multimodal imaging were retrospectively collected. Results A 61-year-old, South-East Asian man, developed CMV-related endotheliitis and occlusive retinal vasculitis, diagnosed by wide-angle fluorescein angiography. No retinitis was present on the fundus examination. Suspicion of CMV etiology was based on anterior segment findings, especially the presence of coin-shaped endothelial lesions. The diagnosis was confirmed by aqueous polymerase chain reaction (PCR) analysis which was positive for CMV DNA. The combined use of topical and systemic valganciclovir resulted in significant improvement of the picture. Conclusions CMV can manifest in the eye as occlusive retinal vasculitis without the presence of typical retinitis. | ||
| 650 | 4 | |a Cytomegalovirus virus |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Uveitis |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Endotheliitis |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Retinal vasculitis |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Retinitis |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Testi, Ilaria |4 aut | |
| 700 | 1 | |a De Benito-Llopis, Laura |4 aut | |
| 700 | 1 | |a Pavesio, Carlos |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of ophthalmic inflammation and infection |d Berlin : Springer, 2011 |g 13(2023), 1 vom: 04. Aug. |w (DE-627)SPR024957690 |w (DE-600)2592309-2 |x 1869-5760 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2023 |g number:1 |g day:04 |g month:08 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1186/s12348-023-00356-z |z kostenfrei |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2023 |e 1 |b 04 |c 08 | ||